ASD Closure Devices
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Immunocell Therapy Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immunocell Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunocell Therapy Market Perspective (2017-2028)
2.2 Immunocell Therapy Growth Trends by Region
2.2.1 Immunocell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immunocell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Immunocell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Immunocell Therapy Market Dynamics
2.3.1 Immunocell Therapy Industry Trends
2.3.2 Immunocell Therapy Market Drivers
2.3.3 Immunocell Therapy Market Challenges
2.3.4 Immunocell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunocell Therapy Players by Revenue
3.1.1 Global Top Immunocell Therapy Players by Revenue (2017-2022)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunocell Therapy Revenue
3.4 Global Immunocell Therapy Market Concentration Ratio
3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2021
3.5 Immunocell Therapy Key Players Head office and Area Served
3.6 Key Players Immunocell Therapy Product Solution and Service
3.7 Date of Enter into Immunocell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunocell Therapy Breakdown Data by Type
4.1 Global Immunocell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Immunocell Therapy Forecasted Market Size by Type (2023-2028)
5 Immunocell Therapy Breakdown Data by Application
5.1 Global Immunocell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Immunocell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immunocell Therapy Market Size (2017-2028)
6.2 North America Immunocell Therapy Market Size by Country (2017-2022)
6.3 North America Immunocell Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Immunocell Therapy Market Size (2017-2028)
7.2 Europe Immunocell Therapy Market Size by Country (2017-2022)
7.3 Europe Immunocell Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunocell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Immunocell Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Immunocell Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Immunocell Therapy Market Size (2017-2028)
9.2 Latin America Immunocell Therapy Market Size by Country (2017-2022)
9.3 Latin America Immunocell Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunocell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Immunocell Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Immunocell Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Immunocell Therapy Introduction
11.1.4 Gilead Sciences Revenue in Immunocell Therapy Business (2017-2022)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Immunocell Therapy Introduction
11.2.4 Novartis Revenue in Immunocell Therapy Business (2017-2022)
11.2.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immunocell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Others
Table 5. Global Immunocell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Immunocell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Immunocell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Immunocell Therapy Market Share by Region (2017-2022)
Table 9. Global Immunocell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Immunocell Therapy Market Share by Region (2023-2028)
Table 11. Immunocell Therapy Market Trends
Table 12. Immunocell Therapy Market Drivers
Table 13. Immunocell Therapy Market Challenges
Table 14. Immunocell Therapy Market Restraints
Table 15. Global Immunocell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Immunocell Therapy Market Share by Players (2017-2022)
Table 17. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2021)
Table 18. Ranking of Global Top Immunocell Therapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Immunocell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immunocell Therapy Product Solution and Service
Table 22. Date of Enter into Immunocell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunocell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Immunocell Therapy Revenue Market Share by Type (2017-2022)
Table 26. Global Immunocell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Immunocell Therapy Revenue Market Share by Type (2023-2028)
Table 28. Global Immunocell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Immunocell Therapy Revenue Market Share by Application (2017-2022)
Table 30. Global Immunocell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Immunocell Therapy Revenue Market Share by Application (2023-2028)
Table 32. North America Immunocell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Immunocell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Immunocell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Immunocell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Immunocell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Immunocell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Immunocell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Immunocell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Immunocell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Immunocell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Gilead Sciences Company Detail
Table 43. Gilead Sciences Business Overview
Table 44. Gilead Sciences Immunocell Therapy Product
Table 45. Gilead Sciences Revenue in Immunocell Therapy Business (2017-2022) & (US$ Million)
Table 46. Gilead Sciences Recent Development
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Immunocell Therapy Product
Table 50. Novartis Revenue in Immunocell Therapy Business (2017-2022) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Research Programs/Design for This Report
Table 53. Key Data Information from Secondary Sources
Table 54. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunocell Therapy Market Share by Type: 2021 VS 2028
Figure 2. Chimeric Antigen Receptor (CAR) T Cell Therapy Features
Figure 3. Natural Killer (NK) Cell Therapy Features
Figure 4. Others Features
Figure 5. Global Immunocell Therapy Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Immunocell Therapy Report Years Considered
Figure 10. Global Immunocell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Immunocell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Immunocell Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Immunocell Therapy Market Share by Players in 2021
Figure 14. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Immunocell Therapy Revenue in 2021
Figure 16. North America Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Immunocell Therapy Market Share by Country (2017-2028)
Figure 18. United States Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Immunocell Therapy Market Share by Country (2017-2028)
Figure 22. Germany Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Immunocell Therapy Market Share by Region (2017-2028)
Figure 30. China Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Immunocell Therapy Market Share by Country (2017-2028)
Figure 38. Mexico Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Immunocell Therapy Market Share by Country (2017-2028)
Figure 42. Turkey Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Immunocell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Gilead Sciences Revenue Growth Rate in Immunocell Therapy Business (2017-2022)
Figure 45. Novartis Revenue Growth Rate in Immunocell Therapy Business (2017-2022)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead Sciences Novartis